HEALTHCARE GLOBAL ENTERPRISES
|
|
BOM : 539787     NSE : HCG     | |
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Average [Stock is fairly valued] Debt : High |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Mild Upward Pledged Shares : None or < 25% |
Nov 12,2024 |
Price(EOD): ₹ 467.55
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Hospital & Healthcare Services |
MCap: ₹ 6,517.65 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
HEALTHCARE GLOBAL ENTERPRISES | -0.1% | 6.2% | 25.1% |
APOLLO HOSPITALS ENTERPRISE | 0.7% | -1.1% | 35.2% |
MAX HEALTHCARE INSTITUTE | -4.7% | 8.9% | 72.8% |
GLOBAL HEALTH | -1.2% | 1.3% | 24.5% |
FORTIS HEALTHCARE | 3.6% | 7.7% | 82.4% |
NARAYANA HRUDAYALAYA | 2.6% | 1% | 22% |
ASTER DM HEALTHCARE | -1% | 5.1% | 31.4% |
DR LAL PATHLABS | -2.3% | -11.4% | 10.2% |
KRISHNA INSTITUTE OF MEDICAL SCIENCES | -0.5% | 2.1% | 49.3% |
FUNDAMENTAL ANALYSIS OF HEALTHCARE GLOBAL ENTERPRISES
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF HEALTHCARE GLOBAL ENTERPRISES
 Ratio | Consolidated | |
---|---|---|
P/E P/B P/S |
106.5
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 61.19 Cr
[Latest Qtr - Sep2024 - Consolidated Results ] 8.06
P/B Calculated based on Book Value of Rs 808.23 Cr
[Latest Year - Mar2024 - Consolidated Results ] 3.19
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 2,043.62 Cr
[Latest Qtr - Sep2024 - Consolidated Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
11% 15% 25% |
SHARE PRICE MOMENTUM OF HEALTHCARE GLOBAL ENTERPRISES
HEALTHCARE GLOBAL ENTERPRISES vs SENSEX
DEBT OF HEALTHCARE GLOBAL ENTERPRISES
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2024 2023 2022 Avg_3yrs |
0.34 0.11 0.1 0.18 |
0.83 0.47 0.47 0.59 |
[Last Annual Data : Mar2024]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF HEALTHCARE GLOBAL ENTERPRISES
Pledged Promoter Shares |
0 % | |
---|---|---|
As on : Dec2023 | ||
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF HEALTHCARE GLOBAL ENTERPRISES
Consolidated | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
5.32% 12.5% 45.68% 51.83% |
13.68% 20.84% 54.38% 91.94% |
QtrlyTrend |
8 | |
Latest Qtr: Sep2024 | ||
Quarterly Result Analysis → |
HEALTHCARE GLOBAL ENTERPRISES related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
S&P BSE ALLCAP | -0.3% | -3.5% | 35.8% |
S&P BSE HEALTHCARE | -1.7% | -2.8% | 50.8% |
S&P BSE MIDSMALLCAP | -1.9% | -5.9% | 39.7% |
S&P BSE SMALL CAP | -2.4% | -5.3% | 39.8% |
You may also like the below Video Courses
FAQ about HEALTHCARE GLOBAL ENTERPRISES
Is HEALTHCARE GLOBAL ENTERPRISES good for long term investment?
As on Nov 12,2024, the Fundamentals of HEALTHCARE GLOBAL ENTERPRISES look Average and hence you may wait for the results to improve to invest for long term ! See Financial Performance of HEALTHCARE GLOBAL ENTERPRISES . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is HEALTHCARE GLOBAL ENTERPRISES UnderValued or OverValued?
As on Nov 12,2024, HEALTHCARE GLOBAL ENTERPRISES is Fairly Valued based on the estimates of intrinsic value and investors may wait for the buying opportunity once it becomes under valued!What is the Intrinsic Value of HEALTHCARE GLOBAL ENTERPRISES ?
As on Nov 12,2024, the Intrinsic Value of HEALTHCARE GLOBAL ENTERPRISES is Rs. 407.33 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 422.80
Fair Value [Median EV / Sales Model] : Rs. 407.33
Fair Value [Median Price / Sales Model] : Rs. 374.13
Estimated Median Fair Value of HEALTHCARE GLOBAL ENTERPRISES : Rs. 407.33
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.